| PERIOD ENDING | 31-Mar-09 | 31-Mar-08 | 31-Mar-07 | | Total Revenue | 33,932 | 35,207 | 48,466 | | Cost of Revenue | 2,819 | 3,593 | 3,794 | | | Gross Profit | 31,112 | 31,615 | 44,672 | | | Operating Expenses | | Research Development |
-
|
-
|
-
| | Selling General and Administrative | 156 | 139 | 133 | | Non Recurring |
-
|
-
|
-
| | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | 30,956 | 31,475 | 44,539 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (86,954) | (44,728) |
-
| | Earnings Before Interest And Taxes | 30,956 | 31,475 | 31,999 | | Interest Expense | 3,750 | 7,373 | 8,568 | | Income Before Tax | 27,206 | 24,102 | 23,431 | | Income Tax Expense |
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | (59,748) | (20,626) | 35,971 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (59,748) | (20,626) | 35,971 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($59,748) | ($20,626) | $35,971 |
|
0.20% Nasdaq 
Income Statement
